Compound Profiles
BPC-157
Body Protection Compound-157 | Pentadecapeptide
Promotes blood vessel formation (angiogenesis), enhances collagen synthesis, modulates growth factor expression including VEGF, and protects against tissue damage through localized or systemic delivery pathways..
Rosuvastatin
HMG-CoA Reductase Inhibitor | Statin for Lipid Management
Rosuvastatin competitively inhibits HMG-CoA reductase, the rate-limiting enzyme in the mevalonate pathway responsible for hepatic cholesterol synthesis. By blocking this enzyme, rosuvastatin reduces intracellular cholesterol in hepatocytes, which triggers upregulation of LDL receptor expression on the liver cell surface.
Combined Organ Load
Shared Safety Flags
Frequently Asked Questions
Can I take BPC-157 with Rosuvastatin?
Yes, BPC-157 and Rosuvastatin can generally be taken together. BPC-157 reduces inflammation while Rosuvastatin promotes tissue repair. Reducing inflammation creates a more favorable environment for healing.
Is BPC-157 and Rosuvastatin safe together?
Based on pharmacological analysis, this combination is considered synergistic. However, shared safety flags include: teratogenic. Monitor accordingly.
What are the interactions between BPC-157 and Rosuvastatin?
BPC-157 reduces inflammation while Rosuvastatin promotes tissue repair. Reducing inflammation creates a more favorable environment for healing. This assessment has 50% confidence and is inferred from pharmacological mechanism analysis.
How should I time BPC-157 and Rosuvastatin?
BPC-157 has a half-life of <30 minutes and Rosuvastatin has a half-life of ~19 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.
This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.